【製薬中堅】高脂血症薬主力。研究開発型企業目指し新薬開発に力。
日付 | 信用売残 (解説) | 信用買残 (解説) | 信用倍率 (解説) |
---|---|---|---|
2023/5/26 | 15,300 | 13,200 | 0.86 |
2023/5/19 | 14,900 | 13,400 | 0.90 |
2023/5/12 | 14,800 | 23,700 | 1.60 |
2023/4/28 | 9,900 | 16,500 | 1.67 |
2023/4/21 | 12,200 | 13,400 | 1.10 |
2023/4/14 | 14,200 | 11,900 | 0.84 |
2023/4/7 | 10,400 | 11,500 | 1.11 |
2023/3/31 | 6,600 | 12,200 | 1.85 |
2023/3/24 | 7,600 | 12,500 | 1.64 |
2023/3/17 | 8,400 | 10,900 | 1.30 |
2023/3/10 | 7,900 | 13,300 | 1.68 |
2023/3/3 | 2,900 | 18,600 | 6.41 |
2023/2/24 | 1,200 | 16,900 | 14.08 |
2023/2/17 | 1,100 | 17,900 | 16.27 |
2023/2/10 | 500 | 19,500 | 39.00 |
2023/2/3 | 2,600 | 24,600 | 9.46 |
2023/1/27 | 5,700 | 14,000 | 2.46 |
2023/1/20 | 4,700 | 14,900 | 3.17 |
2023/1/13 | 4,700 | 15,700 | 3.34 |
2023/1/6 | 1,500 | 13,400 | 8.93 |
2022/12/30 | 2,000 | 13,000 | 6.50 |
2022/12/23 | 5,300 | 16,900 | 3.19 |
2022/12/16 | 1,800 | 20,700 | 11.50 |
2022/12/9 | 1,600 | 21,400 | 13.38 |